Track SABS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
SABS - SAB Biotherapeutics Inc (SABS) has a earnings per share of -$0.35, up 37.1% over the past year.
Latest EPS (Actual)
-$0.35
Beat Rate
37.5%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.21 | -$0.35 | Miss | -69.38% |
| Mar 2026 | -$0.17 | -$0.41 | Miss | -142.12% |
| Nov 2025 | -$0.12 | -$0.21 | Miss | -75.00% |
| Aug 2025 | -$0.82 | -$1.09 | Miss | -32.93% |
| May 2025 | -$1.07 | -$0.56 | Beat | +47.79% |
| Mar 2025 | -$1.21 | -$0.98 | Beat | +18.93% |
| Nov 2024 | -$1.09 | -$1.12 | Meet | -2.75% |
| Aug 2024 | -$1.13 | -$0.79 | Beat | +30.09% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.